THE FUTURE OF MEDICAL CANNABIS THERAPY
Pharmaceutical Standards – Reliable Dosing – Optimized Delivery
A 9-digit-market in
dire need of a
In Germany alone, more than 200,000 patients with various medical conditions ranging from chronic pain, through chemo remedy to epilepsy will be treated with medical cannabis in 2023.
With a total of 380,000 annual prescriptions and over €200,000,000 being reimbursed by German healthcare providers, Medical Cannabis is more than a lifestyle treatment.
It is a fast-growing professional healthcare business with 9 digit revenues and a serious alternative for thousands of patients in need of care.
And yet, there are no solutions for a fast-acting inhalative uptake of medical treatments that are easy to use and safe for the patients.
MEDICAL CANNABIS INHALER
The first Metered Dose Vaporizer for Medical Cannabis Extracts
With the choice between the smoking of cannabis flowers or the oral uptake of tinctures & pills, doctors and patients today have only two options: Quick help or easy handling - but never both.
Our Medical Cannabis Vaporizer closes this gap. Through the gentle evaporation of cannabis extracts, the ingestion of the active ingredient becomes fast, easy and precisely dosed.
Application made fast, easy & safe for the patient
Building on extensive market knowhow and a unique technological approach,
we solve existing core challenges for the application of medical cannabis.
Foundation for therapeutic applications
Advantage over competition
OPTIMIZED AEROSOL PARTICLE SIZE
2x improved delivery to the lungs (compared to flowers)
DEVELOPMENT & DOCUMENTATION
ANALYTICS, CMC DATA & CLINICAL TRIALS
DATA ACCESS AND MOBILE APP
Device certification by medical standards
Proven usability, reliability & safety
Advanced options for therapy, better oversight & control
Innovation & excellence through state-of-the-art materials.
Our Medical Cannabis Vaporizer builds on a unique ceramic dosing technology. It is the first Cannabinoid Vaporization System developed by inhalation industry experts and it is specifically designed for medicinal applications following a coherent pharmaceutical process.
GERMAN MINISTRY OF ECONOMICS
Initial Project Funding
LIFE SCIENCE ACCELERATOR BADEN-WÜRTTEMBERG
12mo accelerator program